Resource Library

CAB PrEP Introduction Situation Analysis – South Africa – 2024

This document summarizes findings from the national situation analysis that can support the creation of a national biomedical HIV prevention platform.

Dapivirine Vaginal Ring Early Market Access Vehicle (EMAV)

In response to the voices of adolescent girls and women who need more HIV prevention choices, The Global Fund (GF) and the Children Investment Fund Foundation (CIFF) have partnered to make dapivirine vaginal rings available in GF-supported countries through an early market access vehicle. See below for EMAV request forms. For guidance on how to…

Financing & Costing, Service Delivery, Supply Chain Management

HIV Rapid Diagnostic Test Market Landscape, 2023

This landscape analysis explores the HIV testing market to assess what factors can help preach global testing targets.

Demand Creation/Marketing, Testing

Vibe with the NextGen Squad

MOSAIC hosts quarterly 90-minute virtual learning sessions for young people to support and raise awareness on available HIV prevention method options. This youth-led and youth-focused webinar series was developed to be a safe space for young people to learn about the HIV prevention methods that are in market or coming to market soon

Empowering Youth in HIV Prevention and Treatment: The role of meaningful youth engagement and innovative, behavioral, and social science-driven approaches

This document outlines the agenda and speaker biographies for a satellite session at AIDS 2024 dedicated to the meaningful engagement of youth in HIV prevention, care, and treatment work, hosted by USAID and the US government’s Bureau of Global Health Security and Diplomacy.

Community/Advocacy

Leading the Way: Early learnings from CAB for PrEP introduction in Zambia and Zimbabwe

Programmatic rollout of long-acting injectable cabotegravir (CAB for PrEP) has launched in Zambia and Zimbabwe! Recommended by the World Health Organization as a safe and effective HIV prevention method in 2022, these two countries are now the first in Africa to incorporate this new, long-awaited PrEP product into their national HIV prevention programs. In the…

Monitoring & Evaluation

Nigeria National Oral PrEP Implementation Plan (2022-24) Assessment Presentation

From October 2023 to April 2024, MOSAIC supported the Federal Ministry of Health to evaluate the National Oral PrEP Implementation Plan (Jan 2022 – Jan 2024). The purpose of the evaluation was to assess the achievement of priority activities stipulated in the National Oral PrEP Implementation Plan (Jan 2022-Jan 2024) against the intended objectives. The…

Monitoring & Evaluation, Normative Guidance/Policies

Generic CAB for PrEP Development and Access

This presentation from Medicines Patent Pool explains the process of licensing, developing, and manufacturing generic cabotegravir (CAB) for PrEP, including expected timelines for generic CAB for PrEP availability.

Community/Advocacy

Ring 101 Slide Deck

These slides give an overview of the dapivirine ring, including basic information about how it's used, clinical trial results, user experience, and upcoming studies and products.

Research

South Africa PrEP Implementation Study Mapping Analysis

This analysis aims to investigate which questions will/will not be addressed by the current slate of ongoing or planned implementation science to inform decisions about investments in additional research (if needed) and provide an understanding of when insights across key questions will become available to help inform the rollout planning for the new PrEP methods…

Research